Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

α toc

Manufactured by Merck Group
Sourced in United States, Germany
About the product

α-Toc is a laboratory equipment product manufactured by Merck Group. It serves as a core component in various scientific research and analysis applications.

Automatically generated - may contain errors

Market Availability & Pricing

Is this product still available?

Get pricing insights and sourcing options

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

Product FAQ

16 protocols using «α toc»

1

Enhancing Radish Drought Resilience with Alpha-Tocopherol

2025
The seeds of two radish genotypes, G1-Laal Pari and G2-Early Milo were acquired from Ayyub Agricultural Research Institute (AARI), Faisalabad-Pakistan. The present research was conducted during the summer (2022) in the old Botanic Garden, the University of Agriculture, Faisalabad (31° 25’44” N, 73° 04’ 18” E, altitude 186 m a.s.l.) to evaluate the effect of exogenously applied α-Toc (Sigma-Aldrich, St. Louis, MO, USA) on Radish under drought conditions. Eight seeds of each variety were relocated to round plastic pots (radius 11 cm and depth 25 cm) filled with 8 kg of soil and poly lining on the bottom of the plants to prevent the leaching of α-Toc. Before seedling, the soil was adequately prepared, following the prerequisites for radish. A factorial experiment was designed as completely randomized design (CRD) with four replications. Two radish genotypes were arranged in 32 pots to apply the drought and alpha-tocopherol (α-Toc) treatments. The average day and night range 20–25 °C and 10–19 °C, respectively, and the photoperiod ranges 10–12 h with relative humidity (RH) ranging from 58.9 to 60.1% on average. During the first two weeks, plants were subjected to normal irrigation levels. After two weeks of completion, irrigation was halted for half of two variants to simulate the drought conditions. Before drought implications, the field capacity (FC) of two pots was monitored by filling them with 8 kg of oven-dried soil overflowing with normal water and leaving them for 1 day on a steel wire stand. When no dripping of water was seen, both of the pots were weighed to determine the saturated weight (SW); after the oven dried at 72 °C for 2 days, soil dry weight (DW) was measured. The percentage of moisture contents was calculated using the following equation [23 ].
Drought stress (DS) was imposed on selective pots of the experimental replicates. For DS stress, 38 ± 3% FC was maintained for a whole growing season and acclimation to the designated drought-level was maintained within two weeks and irrigation was gradually decreased for a two weeks to prevent from sudden evaporative loss. The pots were weighed daily to assess the FC and irrigated as per requirement accordingly to sustain the needed FC. During the DS treatments, the normal FC was provided to absolute controls and parts were reshuffled to prevent border and pseudo-replication effects. Before α-Toc foliar applications the α-Toc solution was prepared in a nominal amount of the methanol and the final volume was maintained by distilled water (dH2O) having a pH of 7.0., a total volume of 20 mL per pot was used. A preliminary experiment was carried out with different concentrations of α-Toc (0, 20, 40, 100 ppm) to ensure positive and negative effects on radish seedlings under drought and sole applications. According to growth results, 100 ppm demonstrates the best sustainability outcomes during drought and sole conditions. Consequently, 100 ppm of α-Toc was used for the main experiment. The foliar exogenous applications of the α-Toc were applied after 30 days of the establishment. The exogenous applications of α-Toc were done before evening to prevent evaporative loss and maximum absorption by the leaves. To enhance the absorption of α-Toc, 0.1% Tween-20, a non-ionic surfactant, was used to reduce the surface tension on the leaf surface. The plant sampling was done after two weeks of drought and α-Toc applications to prevail various growth and biochemical attributes.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Grape Seed Antioxidant Extraction

2024
Grape seeds were purchased at local markets (Changchun, China). Cellulase was purchased from Shanghai Yuanye Biotechnology Co., Ltd (Shanghai, China). Linoleic acid and soybean lecithin (98 % purity) were purchased from Shanghai Aladdin Bio-Chemical Technology Co. Ltd. (Shanghai, China). NBD-PE (N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoetha-nolamine, triethylammonium salt) was purchased from Thermo Fisher Scientific, Inc. (Shanghai, China). α-TOC (96 % purity) was purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). Procyanidins (98 % purity) were purchased from HeFei BoMei Biotechnology Co. Ltd. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) were purchased from Shanghai Macklin Biochemical Co. Ltd. 2-Thiobarbituric acid (TBA) and all other chemicals of analytical grade were purchased from Sinopharm Chemical Reagent Co. Ltd. (Shanghai, China). Ultrapure water was used throughout.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Characterization of ccRCC Cell Lines

2022
The VHL-mutated, human ccRCC cell line 786-O was obtained from Bernhard Brüne (Goethe University, Frankfurt am Main). The 786-O cells, stably transduced with empty vector or FLAG-tagged pVHL, were a kind gift from William Kaelin Jr. (Dana Farber Cancer Institute, Boston, MA, USA). Human embryonal kidney (HEK293T) and human colon carcinoma HT-29 cells were obtained from DSMZ (Braunschweig, Germany).
The 786-O cell lines were maintained in RPMI 1640 medium (ThermoFisher Scientific, Dreieich, Germany), containing 1% penicillin/streptomycin (P/S) (Invitrogen™, Waltham, MA, USA), 10% fetal calf serum (FCS) (Biochrom, Berlin, Germany) and 1% sodium pyruvate (ThermoFisher Scientific). The 293T cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) GlutaMAX™-I medium (Life Technologies, Carlsbad, CA, USA), supplemented with 10% FCS and 1% P/S. HT-29 cells were cultivated in McCoy’s 5A Medium GlutaMAX™-I (Life Technologies, Inc., Eggenstein, Germany), supplemented with 1% P/S and 10% FCS. All cells were maintained at 37 °C in a humidified atmosphere with 5% CO2 and regularly monitored for mycoplasma infections.
Zafirlukast and the PARP-1 inhibitor Olaparib were obtained from Selleckchem (Houston, TX, USA). Human recombinant TNFα was obtained from (Biochrom, Ltd., Berlin, Germany), Nec-1s, GSK’872 and NSA were purchased from Merck (Darmstadt, Germany), carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]- fluoromethylketone (zVAD.fmk) was obtained from Bachem (Heidelberg, Germany), Enbrel (etanercept) from Pfizer (Berlin, Germany), erastin, α-Toc, NAC, BHA were obtained from Sigma-Aldrich. PT-2385 was purchased from BioVision (Milpitas, California, USA), MG-132 from Merck Millipore (Burlington, MA, USA) and VH298 was obtained from Axon Medchem (Groningen, The Netherlands).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Coenzyme Q10 Supplementation Effects

2022
Chromatographically pure CoQ10 was a generous gift from Eisai Co. (Tokyo, Japan). α-Toc and fetal bovine serum (FBS) were purchased from Sigma-Aldrich (St. Louis, MO). Dulbecco’s modified Eagle’s medium (DMEM) and phosphate-buffered saline (PBS) were purchased from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan). 4',6-Diamidino-2-phenylindole (DAPI) was purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). l-Glutamine and a penicillin-streptomycin-mixed solution were purchased from Nacalai Tesque (Kyoto, Japan). LY294002 (LY), a PI3K inhibitor, was purchased from Carbiochem (San Diego, CA). The CoQ10 was mixed with soybean lecithin and dispersed in distilled water, α-Toc was dissolved in ethanol, and LY was dissolved in dimethyl sulfoxide. All other chemicals used were of analytical grade.
The commercially available antibodies were as follows: anti-annexin II (Clone 5) mouse monoclonal antibodies (mAbs; BD Biosciences, San Jose, CA), anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 6C5) mouse mAb, mouse- rabbit–rat control IgG (Santa Cruz Biotechnology, Santa Cruz, CA); anti-phospho-Akt S473 (#4060S) and anti-Akt (#9272) rabbit mAbs, and anti-β-actin rabbit polyclonal Ab (#4967) (Cell Signaling Technology, Beverly, MA); horseradish peroxidase-conjugated secondary Ab (GE Healthcare Bio-Sciences, Piscataway, NJ).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Preparation of Tocopherol Stock Solutions

2021
We purchased α-TOC and α-T3 from Sigma-Aldrich (St. Louis, MO, USA), and γ-T3 from Cayman Chemical (Ann Arbor, Michigan, USA). We prepared a stock solution of 10 mM by dissolving it in ethanol and kept it at −30 °C until use. We carried out further dilutions using phosphate-buffered saline (PBS; Nacalai Tesque, Kyoto, Japan).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Top 5 protocols citing «α toc»

1

Chronic Wound Model in db/db Mice

To generate chronic wounds in db/db mice we performed full thickness 7 mm diameter excision wounds on the dorsum of 6-7-month-old mice. Twenty minutes prior to wounding, mice were treated once intraperitoneally (IP) with 3-amino-1,2,4-triazole (ATZ) (Aldrich Chemistry; St. Louis, MO) at 1 g/kg body weight, an inhibitor for catalase. Immediately after wounding, they were treated once topically with the inhibitor for GPx, mercaptosuccinic acid (MSA), (Sigma Lifesciences; St. Louis, MO) at 150 mg/kg body weight. Immediately after wounding, the wounds were covered with tegaderm (3 M; St. Paul, MN) to prevent contamination and were kept covered for the duration of the experiments. In these mice it is easy to fully remove the hair from the back and hair grows very slowly; hence we had no problems keeping the tegaderm in place. The tegaderm was removed periodically to take pictures of the wound and then immediately replaced. The wounds were fully chronic 20 days after wounding and remained open sometimes for more than 3 months, depending on the experiment. Control db/db mice were treated exactly the same way but instead of inhibitors of the antioxidant enzymes they were treated with the vehicle (PBS). To reverse chronicity, at 20 days, the antioxidant NAC (Aldrich Chemistry (St. Louis, MO)) was topically applied to the wound at 200 mg/kg and the tegaderm replaced. Simultaneously, the mice were injected intraperitoneally with α-toc, Sigma Lifesciences (St. Louis, MO) at 50 mg/kg. This treatment continued with NAC applied to the wound topically every day using an insulin syringe to deposit the solution under the tegaderm and over the wound and with α-toc IP every other day for 20 days (40 days after wounding). At this point, the antioxidant treatment was stopped and the wounds went on to heal around 30 days after initiation of treatment with antioxidants (50 days after wounding). For the antioxidant controls, the mice were treated exactly the same but with vehicle rather than antioxidants. In some experiments, tissues were collected at various time points for detailed histological/histochemical, biochemical, and cellular/molecular evaluation, and in some cases the tissues were analyzed for type and level of bacterial infection/biofilm production. Chronic wounds were successfully created in over 100 animals.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Ferroptosis Induction and Inhibition Assay

Spheroids were collected at day 1 and 10 (L929) and day 1 (SKOV) and seeded at a density of 80 spheroids per well in a 96-well plate in duplicate. A 2D control was seeded as well at a density of 10,000 cells per well. Cells were stained either immediately after seeding (spheroids) or after 24 h (2D culture) using the optimal Sytox Green (L929) or Sytox Blue (SKOV) concentration. An apoptosis inhibitor (zVAD-fmk, BACHEM, Budendorf, Switzerland), necroptosis inhibitor (Nec-1s, Abcam, Cambridge, UK) and multiple ferroptosis inhibitors (Fer-1, DFO and α-Toc, Sigma, Saint Louis, MO, USA) were added 30 min before cell death induction with 5 µM ML-162 (AOBIOUS, Gloucester, MA, USA), an inhibitor of GPX4 and thus an inducer of ferroptosis. After 24 h, Sytox intensity was measured using the Tecan Spark microplate fluorescence reader. Afterwards, cells were permeabilised with the optimal Triton X-100 concentration (found in the previous experiment) to obtain 100% of cell death. After 2 h of incubation, Sytox intensity was measured again.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Antioxidant-Mediated Cytoprotection Protocol

As2O3, α-TOC, L-AA, Primers [Nrf2, Bcl2, glyceraldehyde 3-phosphate dehydrogenase (GAPDH)], Triton X 100, dichlorofluorescein diacetate, and Rhodamine-123 (R-123) were purchased from Sigma-Aldrich, Bangalore, India. RapiGest SF was purchased from Waters India Pvt Ltd, Bangalore, India. Fetal bovine serum (FBS), antibiotic–antimycotic solution, Roswell Park Memorial Institute-1640 medium, ethidium bromide, and all other chemicals were purchased from Himedia Pvt. Ltd (Mumbai, India). As2O3 (1 mM) and L-AA (10 mM) were prepared in aqueous solutions and kept as stock solutions. Stock solution of α-TOC (10 mM) was prepared in 0.2% ethanol. These solutions were diluted to working solutions of As2O3 (10 μM), L-AA (100 μM), and α-TOC (50 μM) on the experiment day before use.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Cell Line Culture and Compound Treatments

ALL cell lines were obtained from DSMZ (Braunschweig, Germany) and cultured in RPMI 1640 or Dulbecco's Modified Eagle Medium (DMEM) medium (Life Technologies, Inc., Eggenstein, Germany), supplemented with 10% FCS (fetal calf serum) (Biochrom, Berlin, Germany), 1% penicillin/streptomycin (Invitrogen) and 25 mM HEPES (Biochrom). The bivalent Smac mimetic BV6, which antagonizes XIAP, cIAP1 and cIAP2 [14 (link)], was kindly provided by Genentech Inc. (South San Francisco, CA, USA). Erastin, Fer-1, DFO and α-Toc were purchased from Sigma-Aldrich (Taufkirchen, Germany), zVAD.fmk from Bachem (Heidelberg, Germany), Nec-1 from Merck (Darmstadt, Germany) and recombinant human TNFα from Biochrom (Berlin, Germany). RSL3 was kindly provided by B. Stockwell (Columbia University, New York, NY, USA) or purchased from InterBIOScreen Ltd. (Moscow, Russia). All chemicals were purchased by Sigma-Aldrich or Carl Roth (Karlsruhe, Germany) unless indicated otherwise.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Cell Culture Conditions for Glioma and Colon Cancer Lines

The human glioma cell lines MZ-5426 (link),29 , LN-229, and U343 GOS-3 as well as the human colon carcinoma cell line HT-29 were cultured in DMEM GlutaMAX medium (Life Technologies, Inc., Eggenstein, Germany) supplemented with 10% fetal calf serum (FCS) (Life Technologies, Inc., Eggenstein, Germany) and 1% penicillin/streptomycin (Life Technologies, Inc., Eggenstein, Germany) at 37 °C and 5% CO2. Cells were regularly tested for mycoplasma infection. Cells were authenticated by STR profiling at DSMZ (Sammlung von Mikroorganismen und Zellkulturen GmbH). Imipramine hydrochloride, ticlopidine, Fer-1, pimozide, epidermal growth factor (EGF), α-Toc, (±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (trolox) and puromycin were purchased from Sigma-Aldrich (St. Louis, Missouri, USA). Loperamide hydrochloride, rapamycin and STS were purchased from Enzo Life Sciences (Lausen, Switzerland). STF-62247 was purchased from Santa Cruz Biotechnology, Inc. (Dallas, Texas, USA), RSL3 from InterBioScreen (InterBioScreen ltd., Russia), etoposide from TEVA GmbH (Ulm, Germany), ABT-737 from Selleck Chemicals (Houston, Texas, USA) and G418 and reduced GSH from Carl Roth (Karlsruhe, Germany). The caspase inhibitor zVAD.fmk was purchased from Bachem (Heidelberg, Germany) and Nec-1s from Biomol (Hamburg, Germany). The Smac mimetic BV6 was kindly provided by Genentech Inc. (South San Francisco, CA, USA). Recombinant human TNFα was purchased from Biochrom (Berlin, Germany).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.